arginine has been researched along with (dtpa-phe(1))-octreotide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bakker, WH; Bernard, BF; Breeman, WA; de Jong, M; Krenning, EP; Rolleman, EJ; Visser, TJ | 1 |
de Jong, M; Kooij, PP; Krenning, EP; Rolleman, EJ; Valkema, R | 1 |
1 trial(s) available for arginine and (dtpa-phe(1))-octreotide
Article | Year |
---|---|
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.
Topics: Arginine; Carcinoma, Neuroendocrine; Female; Humans; Hyperkalemia; Infusions, Intravenous; Kidney; Lysine; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Vomiting | 2003 |
1 other study(ies) available for arginine and (dtpa-phe(1))-octreotide
Article | Year |
---|---|
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.
Topics: Acetazolamide; Animals; Arginine; Cystine; Enzyme Inhibitors; Heptanoates; Kidney; Lysine; Male; Maleates; Octreotide; Pentetic Acid; Radionuclide Imaging; Rats; Rats, Wistar; Sensitivity and Specificity; Tissue Distribution | 1996 |